Progress in Image-planned and Real-time Image-guided Lung Cancer Biopsy
in the Detection of Biomarkers.
10.3779/j.issn.1009-3419.2023.106.15
- Author:
Gengshen BAI
1
;
Bingyin ZHU
2
;
Jun MA
2
;
Yongchun LI
2
;
Gang HUANG
2
;
Yaqiong MA
2
Author Information
1. Department of Interventional, Baiyin Second People's Hospital, Baiyin 730900, China.
2. Department of Radiology, Gansu Provincial Hospital, Lanzhou 730030, China.
- Publication Type:Journal Article
- Keywords:
Biomarker detection;
Biopsy;
Image;
Lung neoplasms
- MeSH:
Humans;
Lung Neoplasms/diagnostic imaging*;
Biopsy;
Biomarkers;
Immunotherapy
- From:
Chinese Journal of Lung Cancer
2023;26(8):630-638
- CountryChina
- Language:Chinese
-
Abstract:
With the progress of targeted therapy and immunotherapy for lung cancer, the clinical demand for lung biopsy is increasing. An ideal biopsy specimen can be used not only for histopathological diagnosis, but also for biomarker detection. The ideal biopsy specimen should meet two requirements, including more than 60 mm2 of tumor tissue and containing more than 20% of tumor cells. In order to obtain ideal lung cancer biopsy specimens, advanced imaging techniques are needed to help. In this article, we reviewed the requirements for biopsy specimens based on biomarker detection, as well as the current status and research progress of using imaging techniques for preoperative planning and intraoperative real time guidance of lung cancer biopsy.
.
